Detailed information for compound 2242983

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 597.152 | Formula: C29H34Cl2FNO5S
  • H donors: 1 H acceptors: 5 LogP: 5.48 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 2
  • SMILES: OC(=O)C[C@]1(C)C[C@@H](c2cccc(c2)Cl)[C@@H](N(C1=O)[C@H](C1CC1)CS(=O)(=O)C(C)(C)C)c1ccc(c(c1)F)Cl
  • InChi: InChI=1S/C29H34Cl2FNO5S/c1-28(2,3)39(37,38)16-24(17-8-9-17)33-26(19-10-11-22(31)23(32)13-19)21(18-6-5-7-20(30)12-18)14-29(4,27(33)36)15-25(34)35/h5-7,10-13,17,21,24,26H,8-9,14-16H2,1-4H3,(H,34,35)/t21-,24-,26-,29-/m0/s1
  • InChiKey: IHUMWHKQAVMWCV-FMWPERMMSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens cytochrome P450, family 3, subfamily A, polypeptide 4 No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) CYP4Cod1 Get druggable targets OG5_126554 All targets in OG5_126554
Brugia malayi Cytochrome P450 family protein Get druggable targets OG5_126554 All targets in OG5_126554
Candida albicans cytochrome P450 56 Get druggable targets OG5_126554 All targets in OG5_126554
Leishmania infantum cytochrome p450-like protein Get druggable targets OG5_126554 All targets in OG5_126554
Candida albicans similar to C.maltosa N-alkane inducible cytochrome P-450, ALK8 CYP52A11 Get druggable targets OG5_126554 All targets in OG5_126554
Candida albicans cytochrome P450 556 Get druggable targets OG5_126554 All targets in OG5_126554
Trypanosoma brucei cytochrome P450, putative Get druggable targets OG5_126554 All targets in OG5_126554
Leishmania mexicana cytochrome p450-like protein Get druggable targets OG5_126554 All targets in OG5_126554
Trypanosoma cruzi cytochrome P450, putative Get druggable targets OG5_126554 All targets in OG5_126554
Candida albicans similar to C.maltosa N-alkane inducible cytochrome P-450, ALK8 CYP52A11 Get druggable targets OG5_126554 All targets in OG5_126554
Leishmania major cytochrome p450-like protein Get druggable targets OG5_126554 All targets in OG5_126554
Trypanosoma congolense cytochrome P450, putative Get druggable targets OG5_126554 All targets in OG5_126554
Brugia malayi Cytochrome P450 family protein Get druggable targets OG5_126554 All targets in OG5_126554
Mycobacterium ulcerans cytochrome P450 185A4 Cyp185A4 Get druggable targets OG5_126554 All targets in OG5_126554
Trypanosoma brucei gambiense cytochrome P450, putative Get druggable targets OG5_126554 All targets in OG5_126554
Candida albicans closely related to C.maltosa N-alkane-inducible cytochrome P-450, alkane hydroxylating monooxygenase CYP52A3-b aka P450Alk1A (BA Get druggable targets OG5_126554 All targets in OG5_126554
Leishmania donovani cytochrome p450-like protein Get druggable targets OG5_126554 All targets in OG5_126554
Trypanosoma cruzi cytochrome P450, putative Get druggable targets OG5_126554 All targets in OG5_126554
Leishmania braziliensis cytochrome p450-like protein Get druggable targets OG5_126554 All targets in OG5_126554
Loa Loa (eye worm) cytochrome P450 family protein Get druggable targets OG5_126554 All targets in OG5_126554
Loa Loa (eye worm) cytochrome P450 family protein Get druggable targets OG5_126554 All targets in OG5_126554
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126554 All targets in OG5_126554
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi cytochrome P450 cytochrome P450, family 3, subfamily A, polypeptide 4 502 aa 492 aa 24.2 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Plasmodium vivax hypothetical protein, conserved 0.0013 0.8119 0.5
Schistosoma mansoni brg-1 associated factor 0.0013 0.8119 1
Echinococcus multilocularis SWI:SNF matrix associated 0.0013 0.8119 1
Trypanosoma cruzi cytochrome P450, putative 0.0015 1 1
Chlamydia trachomatis SWIB complex protein 0.0013 0.8119 0.5
Schistosoma mansoni hypothetical protein 0.0013 0.8119 1
Brugia malayi SWIB/MDM2 domain containing protein 0.0013 0.8119 0.8119
Echinococcus granulosus Upstream activation factor subunit UAF30 0.0013 0.8119 1
Toxoplasma gondii DNA topoisomerase domain-containing protein 0.0013 0.8119 1
Loa Loa (eye worm) cytochrome P450 family protein 0.0015 1 1
Trypanosoma brucei cytochrome P450, putative 0.0015 1 1
Brugia malayi Cytochrome P450 family protein 0.0015 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0013 0.8119 0.5
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.0013 0.8119 1
Echinococcus multilocularis Upstream activation factor subunit UAF30 0.0013 0.8119 1
Loa Loa (eye worm) hypothetical protein 0.0011 0.5833 0.5833
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.0013 0.8119 1
Loa Loa (eye worm) SWIB/MDM2 domain-containing protein 0.0013 0.8119 0.8119
Loa Loa (eye worm) CYP4Cod1 0.0015 1 1
Onchocerca volvulus 0.0013 0.8119 1
Trypanosoma cruzi cytochrome P450, putative 0.0015 1 1
Loa Loa (eye worm) brahma associated protein 0.0013 0.8119 0.8119
Leishmania major cytochrome p450-like protein 0.0015 1 1
Brugia malayi brahma associated protein 60 kDa 0.0013 0.8119 0.8119
Brugia malayi brahma associated protein 60 kDa 0.0013 0.8119 0.8119
Plasmodium vivax SWIB/MDM2 domain-containing protein, putative 0.0013 0.8119 0.5
Chlamydia trachomatis DNA topoisomerase I 0.0013 0.8119 0.5
Toxoplasma gondii SWIB/MDM2 domain-containing protein 0.0013 0.8119 1
Echinococcus granulosus SWI:SNF matrix associated 0.0013 0.8119 1
Mycobacterium ulcerans cytochrome P450 185A4 Cyp185A4 0.0015 1 0.5
Echinococcus multilocularis SWI:SNF matrix associated 0.0013 0.8119 1
Schistosoma mansoni hypothetical protein 0.0013 0.8119 1
Schistosoma mansoni hypothetical protein 0.0013 0.8119 1
Loa Loa (eye worm) cytochrome P450 family protein 0.0015 1 1
Echinococcus multilocularis SWI:SNF matrix associated 0.0013 0.8119 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.102 nM BindingDB_Patents: Homogenous Time-Resolved Fluorescence Assay (HTRF). The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1PBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione S-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography.Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture. ChEMBL. No reference
IC50 (binding) = 0.102 nM BindingDB_Patents: Homogenous Time-Resolved Fluorescence Assay (HTRF). The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1PBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione S-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography.Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture. ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.